Stephan Jackman

Chief Executive Officer at Alzamend Neuro - Atlanta, Georgia, United States

Stephan Jackman's Colleagues at Alzamend Neuro
Terri Hunter

Scientific Advisory Board Member

Contact Terri Hunter

Stephan Jackman's Contact Details
Email (Verified)
***@alzamend.com
Get Stephan Jackman's Email Address
Mobile Number
(XXX) XXX-XXXX
Get Stephan Jackman's Mobile Number
HQ
+1 844-722-6333
Location
Atlanta,Georgia,United States
Company
Alzamend Neuro
Stephan Jackman's Company Details
Alzamend Neuro logo, Alzamend Neuro contact details

Alzamend Neuro

Atlanta, Georgia, United States • 3 Employees
Research

Alzamend Neuro is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Our mission is to rapidly develop and market safe and effective treatments. Our current pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's. 

Details about Alzamend Neuro
Frequently Asked Questions about Stephan Jackman
Stephan Jackman currently works for Alzamend Neuro.
Stephan Jackman's role at Alzamend Neuro is Chief Executive Officer.
Stephan Jackman's email address is ***@alzamend.com. To view Stephan Jackman's full email address, please signup to ConnectPlex.
Stephan Jackman works in the Research industry.
Stephan Jackman's colleagues at Alzamend Neuro are Terri Hunter and others.
Stephan Jackman's phone number is +1 844-722-6333
See more information about Stephan Jackman